Adoption of rimegepant in Denmark: a register-based study on uptake, prescribing patterns and initiator characteristics

Adoption of rimegepant in Denmark: a register-based study on uptake, prescribing patterns and initiator characteristics

Abstract Background Rimegepant, an oral calcitonin gene-related peptide (CGRP) receptor antagonist, is the first drug within its class approved for both acute and preventive treatment of migraine. This study examines its uptake in Denmark. Methods Using nationwide healthcare registry data, we analyz...

Full description

Saved in:
Bibliographic Details
Main Authors: Lanfranco Pellesi, Thien Phu Do, Martin Thomsen Ernst, Jesper Hallas, Anton Pottegård
Format: Article
Language:English
Published: BMC 2025-04-01
Series:The Journal of Headache and Pain
Subjects:
CGRP
Drug utilization
Headache
Medication overuse headache
Pain
Treatment patterns
Online Access:https://doi.org/10.1186/s10194-025-02028-w
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items